ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 573,12
-0,78%
Dow Jones
40 211,72
0,53%
DAX
18 505,09
-0,51%
Brent Oil
83,265
-1,27%
Bitcoin
63 665,13
-1,83%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
18/03/201916h32Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INSMInsmed Inc
04/03/201922h05PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
27/02/201922h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
22/02/201913h33Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
22/02/201913h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
22/02/201913h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
20/02/201914h00PR Newswire (US)Insmed to Present at the Leerink Partners 8th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
15/02/201914h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call on Friday, February 22, 2019NASDAQ:INSMInsmed Inc
14/02/201923h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
04/01/201922h05PR Newswire (US)Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities ...NASDAQ:INSMInsmed Inc
08/11/201822h09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
08/11/201814h30GlobeNewswire Inc.Insmed Announces Changes to its Board of DirectorsNASDAQ:INSMInsmed Inc
06/11/201814h30GlobeNewswire Inc.Insmed to Present at Three November ConferencesNASDAQ:INSMInsmed Inc
30/10/201812h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
30/10/201812h30GlobeNewswire Inc.Insmed Reports Third Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
23/10/201814h30GlobeNewswire Inc.Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018NASDAQ:INSMInsmed Inc
11/10/201814h30GlobeNewswire Inc.Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatmen...NASDAQ:INSMInsmed Inc
04/10/201822h30GlobeNewswire Inc.Insmed Extends Patent Protection in Japan to 2033NASDAQ:INSMInsmed Inc
01/10/201814h00GlobeNewswire Inc.Insmed to Present at Two October ConferencesNASDAQ:INSMInsmed Inc
28/09/201823h58GlobeNewswire Inc.Insmed Announces FDA Approval of ARIKAYCE® (amikacin liposome inhalation suspension), the First and Only Therapy Specificall...NASDAQ:INSMInsmed Inc
17/09/201814h00GlobeNewswire Inc.Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Publishe...NASDAQ:INSMInsmed Inc
07/08/201823h30GlobeNewswire Inc.FDA Advisory Committee Votes 12-2 in Favor of the Safety and Effectiveness of Insmed’s ALIS for the Treatment of NTM Lung D...NASDAQ:INSMInsmed Inc
02/08/201813h30GlobeNewswire Inc.Insmed Reports Second Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
26/07/201814h00GlobeNewswire Inc.Insmed to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 2, 2018NASDAQ:INSMInsmed Inc
15/06/201814h00GlobeNewswire Inc.Insmed Announces FDA Advisory Committee Meeting to Review ALIS as a treatment for NTM Lung Disease Caused by MACNASDAQ:INSMInsmed Inc
07/06/201814h00GlobeNewswire Inc.Insmed to Present at Three June ConferencesNASDAQ:INSMInsmed Inc
31/05/201822h27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
22/05/201823h15GlobeNewswire Inc.Insmed Announces Presentations at the American Thoracic Society 2018 International ConferenceNASDAQ:INSMInsmed Inc
17/05/201822h05GlobeNewswire Inc.Insmed Appoints Leo Lee to its Board of DirectorsNASDAQ:INSMInsmed Inc
16/05/201814h00GlobeNewswire Inc.Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MACNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
EU
ORA
Orange
NYSE
MCD
McDonalds
EU
CS
Axa
EU
LR
Legrand
EU
PX1
CAC 40
NYSE
KO
Coca Cola
EU
RI
Pernod Ricard
EU
PX4
SBF 120
EU
AF
Air FranceKLM
COIN
BTCUSD
Bitcoin
EU
ACA
Credit Agricole
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés